These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Diagnostic value of biopsy in gangliopulmonary sarcoidosis.
    Author: Centea A.
    Journal: Z Erkr Atmungsorgane; 1977 Jul; 149(1):84-6. PubMed ID: 607634.
    Abstract:
    In order to be well determined the diagnosis of sarcoidosis needs multiple evidence of clinical, radiological, immunobiological and humoral order, and a histopathological confirmation too. Our casuistry covered 173 observations: Stage I with 94 (54.33%) cases, stage II with 68 (39.3%) cases, and stage III with 11 (6.4%) cases. In 136 patients one or several biopsies were performed with a histopathological result for sarcoidosis in 107 cases (61.8%). According to their character, biopsies could be divided into three groups: Group I comprised 39 biopsies of some easily accessible lesions (skin lesion, peripheral adenopathy, tonsils a.s.o.). 25 of them were concludent for sarcoidosis (64.1%). Group II was made up of 118 biopsies of some hardly accessible lesions (hepatic biopsy puncture, bronchoscopy, pre-scalene node biopsy). Of these biopsies, 22 pleaded for sarcoidosis (18.6%). In group III entered 67 deep biopsies (mediastinoscopy, hiloscopy, thoracotomy with pulmonary biopsy). All of them confirmed sarcoidosis. If to the concludent histopathological result for sarcoidosis (61.8%) we add the one given by the Kveim test (15.1%) (in cases without biopsy or with a non-concludent biopsy) the percentage of biopsy confirmation rises to 76.9%).
    [Abstract] [Full Text] [Related] [New Search]